- Filed
- May 7, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · May 2, 2025 | 238.73M sh |
| Cash And Equivalents | Q1 2025 · Mar 31, 2025 | $71.63M |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $103.15M |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $53.5M |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $55.54M |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $137.15M |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $139.66M |
| Current Assets | Q1 2025 · Mar 31, 2025 | $351.81M |
| Current Assets | Q1 2025 · Dec 31, 2024 | $331.41M |
| Total Assets | Q1 2025 · Dec 31, 2024 | $488.68M |
| Total Assets | Q1 2025 · Mar 31, 2024 | $350.88M |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 236.41M sh |
| Capex | Q1 2025 · Mar 31, 2024 | $2.35M |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | −$2.22M |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | $0.08 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | $0.08 |
| Sga Expense | Q1 2025 · Mar 31, 2024 | $15.64M |
| Rd Expense | Q1 2025 · Mar 31, 2024 | $450K |
| Rd Expense restated | Q1 2025 · Apr 1, 2019 | $300K |
| Net Income | Q1 2025 · Mar 31, 2024 | $17.81M |
| Operating Income | Q1 2025 · Mar 31, 2024 | $21.82M |
| Gross Profit | Q1 2025 · Mar 31, 2024 | $39.11M |
| Cost Of Revenue | Q1 2025 · Mar 31, 2024 | $42.77M |
| Revenue | Q1 2025 · Mar 31, 2024 | $81.88M |
| Stockholders Equity | Q1 2025 · Dec 31, 2023 | $135.21M |